Please login to the form below
personalised medicine
This page shows the latest personalised medicine news and features for those working in and with pharma, biotech and healthcare.
NICE plans to widen the net for data it uses in guidance
That update is intended to take into account developments such as personalised medicine, digitisation of health and use of cell and gene therapy.
Latest news
-
Immuno-oncology, personalised medicine continues to drive pharma sector
or personalised medicine as the most significant trends that will shape the pharma sector this year. ... Last November, GlobalData identified personalised medicine as a key improvement in the treatment pathway, but said that gaining access to these
-
AZ, Merck’s Lynparza narrowly scores FDA approval for pancreatic cancer
We are pleased with the ODAC’s recommendation for Lynparza and the potential to bring a personalised, biomarker-targeted medicine to patients with germline BRCA-mutated metastatic pancreatic cancer,” said José
-
Four digital health trends set to reinvent and re-energise pharma
For example, Abilify MyCite is the first ‘digital medicine’ approved by the FDA in the US. ... This is a fine illustration of the new era of personalised medicine – and the advantages aren’t just for the small number of patients in the pilot
-
Personalised medicine can improve treatment, but access still an issue
By identifying patient subgroups through biomarker analysis, personalised medicine will help identify which groups may benefit from a given treatment,” said Michael Breen, associate director at GlobalData. ... GlobalData's report also highlights that
-
NICE unveils long-awaited review of methodologies
He added: “NICE is undertaking this review at a time of unprecedented change in the healthcare system, where developments such as personalised medicine, digitalisation of health, and use of cell and
Immuno-oncology, personalised medicine continues to drive pharma sector
AZ, Merck’s Lynparza narrowly scores FDA approval for pancreatic cancer
Four digital health trends set to reinvent and re-energise pharma
NICE unveils long-awaited review of methodologies
More from news
Approximately 12 fully matching, plus 108 partially matching documents found.
Latest Intelligence
-
How early-stage clinical research is facilitating the new wave of personalised medicines
By Jorg Taubel. The transformative potential of personalised medicine in improving health outcomes has been well documented. ... We are fortunate that, in the UK, the government and the NHS committed early to embedding a personalised medicine approach
-
Alzheimer’s: the search for a cure
A new prospective study with that molecule is currently ongoing. Personalised medicine. ... Another area of interest in the search for a cure is in personalised medicine.
-
The promise of precision medicine
Diabetes is a particularly complex disease, which involves more than one gene type, and is therefore an area where the use of personalised medicine could help healthcare professionals diagnose more targeted ... treatment. The world- class Sidra Medicine
-
Rare genetic diseases – what’s in store for 2021?
Why personalised medicine based on our own genomes is the future of healthcare. ... There have been numerous breakthroughs in recent years, which have made it clear that personalised medicine based on our very own genomes is the future of healthcare.
-
Think fast, be different: succeeding at speed chess in 2021’s COVID-19 world
EBCs also demonstrate positive data and are bringing novel therapies to market in complex areas of medicine, including gene therapy, CAR T-cell therapy and rare diseases. ... The development of some key, novel personalised medicine approaches in oncology
How early-stage clinical research is facilitating the new wave of personalised medicines
Alzheimer’s: the search for a cure
The promise of precision medicine
Rare genetic diseases – what’s in store for 2021?
Think fast, be different: succeeding at speed chess in 2021’s COVID-19 world
More from intelligence
Approximately 6 fully matching, plus 36 partially matching documents found.
Latest appointments
-
BMS appoints new commercial leader, Davies joins Eisai and more
The field of genomic medicine has the potential to revolutionise our approach to rare genetic disease diagnosis and management, as well as in other areas of personalised medicine.”.
-
Stephen Eck joins Aravive Biologics
chairman of the board of directors of the Personalised Medicine Coalition.
-
FlowMetric Diagnostics names president
It is a great time for the development of new flow cytometry-based companion diagnostics which can help advance personalised medicine and better meet the needs of physicians, healthcare workers and
-
GlobalData makes Americas appointment
Dr Bonnie Bain, global head of healthcare at GlobalData, adds: “Sean is widely recognised as an expert and thought leader in personalised and translational medicine, and it's great to welcome
-
Roche appoints new oncology research head
Personalised cancer has been his forte, however, and he has served as director of personalised cancer medicine at Vanderbilt. ... I was particularly attracted to Roche as one of the pioneers and front-runners in personalised medicine, as the world's top
BMS appoints new commercial leader, Davies joins Eisai and more
Stephen Eck joins Aravive Biologics
Roche appoints new oncology research head
More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.
Latest from PMHub
-
In the precision medicine era, the line between products and services is blurred
Personalised and precision medicine, however, can offer specialised treatments that target the patient’s unique cancer subtype, its genetic mutations, and the affected tissues. ... Optimising the service behind the personalised and precision medicine
-
Making a difference with patient support
Empowering the patient. Providing a stepping-stone to personalised medicine. Reassuring HCPs that the treatment is a both viable option for the patient and that it is adequately supported.
-
Perspective: the patient edition
The ALS patient journey. An article on CAR-T service design. Thought provoking content on clinical trial access and the social determinants of healthcare, and on precision and personalised medicine.
-
Spotlight interview: 15 minutes on Independent Medical Education
By looking at futuristic things that are already impacting healthcare for example artificial intelligence, and personalised medicine, , we have a real opportunity for IME to make an impact on both medical ... There will be many more “small group” or
-
Five key trends in precision and personalised healthcare
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies can ... Innovative pricing models in precision and
More from PMHub
Approximately 4 fully matching, plus 26 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Senior Account Director, Medical & Brand Communications, Lon...
-
Highly competitive salary
- Account Director, Medical & Brand Communications, London/ SE...
-
Highly competitive salary
- Freelance Scientific Director, Medical Communications, London/ S...
-
Highly competitive salary
- Medical Writers (All levels) Editorial / Scientific Leads & ...
-
Highly Competitive Remuneration packages
-
CEO Pricing & Market Access, UK
-
Six figure salary
- Senior Account Management Trainer, Medical Communications, Londo...
-
Highly competitive salary
- Editorial Director - UK, , EUROPE, REMOTE.
-
Highly Competitive Salary, Bonus &Benefits
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Embattled Biogen talks up Aduhelm
- First oral antiviral drug for COVID-19 reviewed by Health Canada
- David Hunt launches independent agency The Considered
- EU “still interested” in Valneva COVID vaccine despite UK snub
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- FDA’s director and deputy director of its Office of Vaccines Research & Review resign
- New data from Moderna supports COVID boosters
- $47.5m research centre to seek genetic insights into disease
- Havas Life Medicom and ARK lead at 2021 PM Society Digital Awards
- Nicky Hutchens appointed as deputy managing director at Four Health
- Health For All
- Digitalizing Muskuloskeletal Care to Improve Patient Outcomes and Reduce Cost
- Oxford PharmaGenesis wins Communiqué Medical Affairs Agency of the Year award at Communiqué 2021
- David Hunt launches independent agency The Considered
- EU “still interested” in Valneva COVID vaccine despite UK snub
- Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
- Future of MHRA uncertain amid Brexit-fuelled shake up
- $47.5m research centre to seek genetic insights into disease
PMHub
An agency called Owen
We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....
Latest intelligence
- Health literacy in the time of COVID-19
- In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
- Rare thoughts & outcomes - navigating pathways to better outcomes in rare
- ...
- How to pick the perfect training program for your healthcare professionals
- You know your team needs training. But not all training providers and programs are created equal. Last week, we shared the benefits of working with specialist learning and development (L&D)...
